Company intelligence
GSK
About GSK
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia
Verified activity
Signals from GSK
39 published signals
Presence & Recognition
GSK is attending the ERSCongress to meet global experts and shape the future of respiratory medicine with its pipeline targeting key inflammatory pathways of respiratory disease with longer-acting solutions.
Reported by GSK
Research & Knowledge
GSK published a new Custom Content article from The Wall Street Journal by Hesham A. Abdullah, MD, MSc and Chris Sheldon, PhD, sharing their approach to oncology business development.
Reported by GSK
Research & Knowledge
GSK accelerated research programmes are looking to target multiple inflammatory pathways, including TSLP and IL-33, to build a diverse portfolio for COPD patients.
Reported by GSK
Presence & Recognition
GSK participated in the ERSCongress COPD activity.
Reported by Dee Postles
Research & Knowledge
GSK published the AI Asset Register Part 2: Classification in the AI Auditor series.
Reported by Najwan H.
People
GSK is hiring for the Gyn Onc TLL team to grow its experience and interests
Reported by Allison Parrish
People
GSK is hiring for the Gyn Onc TLL team to grow its experience and interests
Reported by Allison Parrish
Strategy & Corporate Development
GSK implemented a variety of deals in oncology business development that bring together science and capabilities to change the course of cancer treatment.
Reported by Chris Sheldon, PhD
Presence & Recognition
GSK is hosting a podcast episode titled ERSCongress on the COPD pipeline and breathing challenges at the ERSCongress conference.
Reported by GSK
Presence & Recognition
GSK colleagues and the Respiratory expert community attended the ERSCongress event
Reported by Antonio Blanco
People
GSK is hiring a Medical Director for ViiV Healthcare in Durham, North Carolina to join the U.S. Medical Affairs team.
Reported by Judith Martin
People
GSK welcomed James to Working Animals International as its new CEO.
Reported by Marianne Davies
People
GSK is hiring a Senior Director, R&D AI & Technology Portfolio to join the R&D Technology Transformation organisation.
Reported by Esmae Matthews
People
GSK is hiring a Senior Director, Early Development Leader based in Durham, NC, Pennsylvania, and Branford, CT to lead global, multidisciplinary development teams and drive early development milestones.
Reported by Judith Martin
Presence & Recognition
GSK is hosting a webinar organised by the Royal Society of Chemistry Process Chemistry and Technology interest group titled Adaptive Chemistry Team: Accelerating Early Oncology Discovery Programs on 29 September 2026
Reported by Alan Steven
Presence & Recognition
GSK shared findings from 37 research projects across its portfolio of vaccines, inhaled therapies, and biologics at the ERSCongress.
Reported by GSK
Presence & Recognition
GSK is attending the ESMO Molecular Analysis For Precision Oncology Congress 2026 in London next week.
Reported by Marco Ranzani
Presence & Recognition
GSK Italia participated in the Cernobbio2026 event hosted by Milan Finanza and Class CNBC.
Reported by Antonino Biroccio
Presence & Recognition
GSK is advancing more sustainable respiratory care to protect respiratory health and the planet for future generations.
Reported by GSK
People
GSK is seeking a Senior Director, Strategy, Execution & Planning for ViiV Healthcare in Durham, NC.
Reported by Judith Martin
People
GSK is hiring for two different Pharmaceutical Sales Representatives positions for Greater Baltimore and Bel-Air, Maryland.
Reported by Thaddeus Fox
Presence & Recognition
GSK participated in the Forum of Cernobbio to discuss the future and competitiveness of the Italian economy.
Reported by Antonino Biroccio
Presence & Recognition
GSK attended the Ibec President’s Dinner at RDS showcasing Ireland’s talent, ambition and innovation, with Taoiseach Micheál Martin opening the event.
Reported by Jo-Anne Dodd
Strategy & Corporate Development
GSK announced that North Carolina at enrollment reached new-activity
Reported by Harry D. Sutton, Jr